Isaac Johnson

CEO at Verinnogen

Isaac Johnson is currently the CEO at Verinnogen, where Isaac leads the development of innovative tools for pre-clinical cancer research. Prior to their role as CEO, Isaac worked as a Scientist at Artios Pharma Ltd and held various research positions at the University of Cambridge. Isaac earned a PhD in Oncology and Cancer Biology from the University of Cambridge after completing a BSc in Biomedicine from the University of East Anglia.

Links

Previous companies

University of Cambridge logo
Artios Pharma logo

Org chart

Sign up to view 1 direct report

Get started


Teams

This person is not in any teams